The membrane separates the protein-containing compartment from the protein-free compartment without preventing movement of small, unbound drug molecules. Protein-bound drug remains with the macromolecule, whereas free drug can redistribute between chambers. This selective permeability makes the final concentration difference interpretable as a measure of the drug’s free and protein-bound fractions.
After diffusion has reached equilibrium, the freely mobile drug distributes between the two chambers, while the protein-associated fraction remains in the protein-containing side. Comparing drug concentrations across the chambers therefore indicates how much is unbound versus retained through protein binding. A larger bound fraction corresponds to stronger association with the macromolecule under the tested conditions.
If another compound competes for protein-binding sites, it can change the amount of drug associated with the macromolecule and consequently change the free fraction measured after equilibrium. This matters clinically because altered binding can modify drug availability. Equilibrium Dialysis can therefore help identify potential displacement interactions and characterize how binding changes in combined-compound settings.
A protein-containing sample and a comparison compartment are separated by a semipermeable membrane, then maintained until small unbound molecules diffuse and the system reaches equilibrium. Investigators measure the drug concentration on the relevant sides and use the resulting difference to estimate free and protein-bound fractions. The membrane must retain the protein while permitting small solutes to move.
The method is useful when researchers need to characterize protein binding as part of drug distribution, pharmacokinetics, or dose-response investigations. Its measurements help distinguish the fraction available in an unbound form from the fraction associated with plasma proteins. That information can clarify how binding behavior relates to drug availability across clinical research questions.
Equilibrium Dialysis provides binding information that can complement measured drug concentrations during therapeutic drug monitoring. Knowing the free and protein-bound fractions helps researchers interpret how much drug may be available relative to the total measured amount. The same data can clarify pharmacokinetic behavior, distribution patterns, and the possible clinical significance of changes in protein binding.